-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Jf1HGFVjTgxApEf/040KZYNn/3LzQI+w6uHRBoUCJFyUANGATB6D0J1bhj9JvMZE
 uST6n9ipWEWdCHN7ZSJXTg==

<SEC-DOCUMENT>0001193125-04-220753.txt : 20041229
<SEC-HEADER>0001193125-04-220753.hdr.sgml : 20041229
<ACCEPTANCE-DATETIME>20041229141812
ACCESSION NUMBER:		0001193125-04-220753
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20041228
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20041229
DATE AS OF CHANGE:		20041229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CARDIMA INC
		CENTRAL INDEX KEY:			0001022570
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				943177883
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22419
		FILM NUMBER:		041230628

	BUSINESS ADDRESS:	
		STREET 1:		47266 BENICIA STREET
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		5103540300

	MAIL ADDRESS:	
		STREET 1:		47266 BENICIA ST
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%"
SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Pursuant to Section 13 or 15(d) of the </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report: December 28, 2004 (Date of earliest event reported) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="6"><B>CARDIMA, INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>000-22419</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>94-3177883</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or Other Jurisdiction of</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>Incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(I.R.S. Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>Identification Number)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>47266 Benicia Street, Fremont, California</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>94538</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>(510) 354-0300
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Registrant&#146;s telephone number, including area code) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see </I>General Instruction A.2. below): </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On December 28, 2004, Cardima, Inc. received a notice
from The Nasdaq Stock Market stating that Cardima, Inc. had regained compliance with Nasdaq Marketplace Rule 4310(c)(2)(B). A copy of the press release regarding receipt of the notice from The Nasdaq Stock Market is attached as Exhibit 99.1 to this
Report and is incorporated herein. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item 9.01 Financial Statements and
Exhibits. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>(c)</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibits</B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of Cardima, Inc. dated December 29, 2004.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">CARDIMA, INC.</FONT></P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Date: December 29, 2004</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">/s/ Barry D. Michaels</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Barry D. Michaels</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Interim Chief Financial Officer and Secretary</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">3 </FONT></P>

</BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px">

<IMG SRC="g78610img_002.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>COMPANY CONTACT:</B></FONT></P><HR WIDTH="140" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>INVESTOR CONTACTS:</B></FONT></P><HR WIDTH="147" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>MEDIA CONTACTS:</B></FONT></P><HR WIDTH="124" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Cardima, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Investor Relations Group</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Investor Relations Group</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Barry D. Michaels</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Gino De Jesus</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Janet Vasquez</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Interim Chief Financial Officer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">John Nesbett</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Dian Griesel, Ph.D.</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">(510) 354-0300</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">(212) 825-3210</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">(212) 825-3210</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><U>www.cardima.com</U></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><U>FOR IMMEDIATE RELEASE</U>
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>NASDAQ NOTIFIES CARDIMA IT HAS REGAINED COMPLIANCE WITH
LISTING REQUIREMENT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>FREMONT, Calif. (December 29, 2004)</B> &#150;
<B>Cardima<FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">, Inc. (Nasdaq SC: CRDM),</FONT></B><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"> developer of the INTELLITEMP&reg; and REVELATION&reg; series of cardiac interventional systems for the treatment of atrial fibrillation (AF), today reported that it has received written notice from Nasdaq dated December 28, 2004,
that Nasdaq&#146;s Staff has determined the Company has regained compliance with Nasdaq Marketplace Rule 4310(c)(2)(B) (the &#147;Rule&#148;), which requires that the Company maintain stockholders&#146; equity of not less than $2.5 million, or $35
million market value of listed securities, or $500,000 of net income from continuing operations. </FONT></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">On November 17, 2004, Nasdaq&#146;s Staff notified the Company that it did not comply with the minimum requirements of stockholder&#146;s equity, or market value of listed securities, or net income from continuing
operations requirements for the Rule. Since then, the Company&#146;s market value of listed securities has been $35 million or greater for 10 consecutive trading days. Accordingly, the Nasdaq notice to the Company stated that the Company has
regained compliance with the Rule, and the matter is now closed. The continued listing of the Company&#146;s common stock on Nasdaq will depend on the Company&#146;s continued compliance with all of Nasdaq&#146;s listing requirements. </FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>About Cardima </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Cardima, Inc. has developed the REVELATION&reg; Tx, REVELATION T-Flex and REVELATION Helix linear ablation microcatheters, the NAVIPORT
deflectable guiding catheters, and the INTELLITEMP energy management system for the minimally invasive treatment of atrial fibrillation (AF). The REVELATION Helix was developed for the treatment of AF originating in the pulmonary veins of the heart.
The REVELATION Tx, REVELATION T-Flex and REVELATION Helix systems and the INTELLITEMP have </FONT>
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2">received CE Mark approval in Europe. The Company has also developed a Surgical Ablation System, which targets market application by cardiac surgeons to
ablate cardiac tissue during heart surgery using radio frequency (RF) energy. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Except for the historical information contained herein, the matters discussed in this press release, including potential future events relating to the listing of the Company&#146;s common stock on Nasdaq, are forward-looking statements that
involve risks and uncertainties that could cause actual results to differ materially from those expressed in or implied by such forward-looking statements. Potential risks and uncertainties include the risk that the Company will not be able to
maintain the listing of its common stock on Nasdaq; the risk that the Company will not be able to raise additional capital when needed to continue operations; the risk that the Company will be unable to obtain U.S. FDA approval for the
Company&#146;s PMA for the REVELATION&reg; Tx linear ablation microcatheter system, including uncertainties associated with its ability to revise the study design and collect data acceptable to the FDA; the risk that the approval process for the
REVELATION Tx or any other product, including additional clinical trials, will require substantial unanticipated expenses and management attention; the limited number of cases employing the Company&#146;s products and the limited amount of follow-up
information involving these cases; uncertainties associated with the Company&#146;s ability to secure distribution partners and its ability to consummate the sale of or other strategic transaction involving its Surgical Ablation System; the
possibility of business disruption or unanticipated expenses due to the Company&#146;s staffing reduction and financing efforts; and uncertainties associated with its ability to conduct successful clinical trials, obtain and maintain regulatory
approvals, gain acceptance for the Company&#146;s products from the marketplace or successfully manufacture, market, sell and distribute its products. Additional risks are set forth in the Company&#146;s Quarterly Report on Form 10-Q for the quarter
ended September 30, 2004 and Annual Report on Form 10-K for the year ended December 31, 2003. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events
or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company&#146;s plans or expectations. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"># # # </FONT></P>
</BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g78610img_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g78610img_002.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`9P!D`P$1``(1`0,1`?_$`),```$$`P`#`0``````
M```````("0H+!08'`0($`P$!`0$```````````````````$"$```!@(``P4#
M!@D("@,````!`@,$!08'"``1"1(3%!4*(187,=$BDE,905&R(R1T-1@:H3+3
MUI<X6%EA<9&Q8C2T);=X0G(S$0$!``,!`0```````````````5$"$C$A_]H`
M#`,!``(1`Q$`/P"-M,=?OK*-Y6101Z@.;$T47:R:9`+31`I"F]A0$:L(^S@,
M;_$`]9C_`#!,V_4IG]5>`/X@'K,?Y@F;?J4S^JO`'\0#UF/\P3-OU*9_57@/
M8G7^ZS:BB:274!S@JJLH1)%))*G**K*J&`B:229*H8ZBJAQ`"E*`B(CR#@)<
M_2/U,]0WN"QKF<-Y>HALKJ]KU*ILI6$QZV:TIAL#DR&=$*Y1<IL9&FK-\5P+
M]L8HD=2**LH<IP,FR*42K<`Y_P!37U"FDO2EK_P0A;#-;6;15B'1AB8JKUM2
MF9&!D&K)--"3SIE!=-\RK\DY5,55RU(FZF%3&$1:HD,4X!`BW%]1EU5]O[FK
M.*[#S>O](:/U75:Q7KX<]%KD*D)E2MO,IP@N;?;7Z2"O9,M(OE2=KF*:20#V
M02V>!&OWL74R_P`=>S7]J5@_I^-=;9H/O8NIE_CKV:_M2L']/PZVS0?>Q=3+
M_'7LU_:E8/Z?AUMFB>QZ0/9G839O6C<"P["YER'F:;K6>JA"U^4R'97]E>PT
M4OCY!XX81R\@HH=JU7=&[PQ"<BB?V\N?$MM]$OKB"@]GOVW*_KR_Y7`8G@#@
M.JX1P=ES9+*=.PE@F@6/)^5+]*(P]4IE68G?2DBZ5'FHLJ/T6T=%L40,L[>.
M3I-6B!#*JJ$(43`%E_T;/3<:Z=-VLQFU>[SV@Y=VBKT,:WKR-B59GP?K6BS9
M>8R#BO#.BC%3MFKZ"9Q<V>0(1%J)#&9)H@7Q"H,Y]<7U45JR:\N.JG3'M3^G
MXT16?5S(.V,8*K&W7]-,56DE$X4,JF1U5*DL8!(-@$"2;\GM:`V2$%5@@_.W
M3I^[=R#]TY?R$@Z</G[]ZNJ[>OGKM4Z[IX]=N#J.'3MRNH8ZBAS&.<YA$1$1
MX#\.`.`.`.`L;/1(?W3]W/\`V.I?_C5OP$VS@*#V>_;<K^O+_E<!B>`[7KIK
MKF3;'-5`U[P#29+(&5\ES:$'6*[&E[)>V8!5?2\N]/R;0]>@V)%'3]ZN8B#5
MLD=0Y@`.`MG.CQT:M<>CA@*1LL](U:U[%3E54F]@]D9Y-M&L8N,CF8RTO5J<
M_EQ3]S\65@J!SJ'.9%60%'Q;T0Y)I(!"R]0MZA*T[_6RR:EZF6>5K&D]4E5H
MVSV>,6=1<MLU-1;KD,I)F`$'C7$S)VAVHR--V?,C%!V[*/YA%`(H@`````'(
M`]@`'L``#Y``.`\\`<`<`<`<!8V>B0_NG[N?^QU+_P#&K?@)MG`4'L]^VY7]
M>7_*X#Y(^/?RT@PB8EB[E):5>M(R+C(]NJ[?R4D_73:L8]BT0*==T\>.E2II
M)D*)CG,```B/`6PWIV.BG`=,O7MKF',M>8OMV,[5YB_R)).DD7*^'Z8^!"2B
ML-5Q<0/X1TU$$U[$X2-^F2901`3(-$3&!AOU6O6T?VNQ67I<ZOVQ9M4*ZJW0
MV\O<`^%,;/84SINV^"(YZU.!S0<"8B:UD[)NRY>B1@;Z#=R14(*0!R]@>P`]
M@`'X.`.`.`.`.`.`5AJ)HSMEO?D)OC35#!]UR]8!703EY&%8>$IM2;+*I$-(
MW.\21FE6J[%(BO;YNW2:BA0$$R'-R*(6$&I6K>7_`$R'1@W=SMDF]X_R9L#9
MU(;(L/4X6/DG&/:;D>6CXC&U%K"TRZ6CI*Z(-IJ83=2"A$&*2A43)(]HH]\8
M'&?O@)3[@S[UWR6L_%#]W#SOW7[*WNK\?O._A;X#P/BO&>[OQ+_2O"=_WWE_
MYOO.U]/@*BR>_;<K^O+_`)7`2WO21],6-VDVFLF[V68!.4Q#J+)1[;'<=)-@
M6B[7L+*M?'0[I1)7\R[;8P@SA*"'(W8DW3`WR%$.`G#]:S?W[MSIW9QV'A%V
MY<H.X]MC+"+5P4BA5LLW\KB*K<B9N8Y/$H51J1U-+)^T%$HXQ!]AN`IEIF9E
M[',S%CL,F]F[#8961G9Z:DEU'4E,34N\6D)65D'2IC*N7T@^<'554.(F.<PB
M(B/`8W@#@#@/!C%*',Q@*'XQ$`#^7@',-(^C]U$>H.^8GUOUON,C272J9%\N
MWIN;'N)&*)R@<7(76S)LV<R!$Q$W<QA'SDX`($3,/LX":7H!Z-O7K&1X>]=0
M'+$AL1:T#-GIL/XS4E*+A]BN0R2PLIVQF,WOEV33.02F[HT*B8!$#)J![>`F
M$X9P;AS7:A0^+L$XQH^),>P"":$54:#7(RM0K8$TRI=\=K&-T`=O52D#O7"P
MJ+K&^D<YC"(\!'7]7?.NHGHYW"/;K&2)9\_8-A'A2F$HKM4IN3G11'E_.*+B
M%3,(?\/`1O\`W\E?X,SR7Q!^Y_?(^'W\X>?E/QJ]]>X_^OC?;R^3@(?%A-V9
MB8-\O9>.3<OQ\AY\!<2^GTUCB=5^DCJ!46C`C2?R)C]#.MX<=D07D;5F$_OB
M*[DQOSASL:^]8,B=H1[*30A0Y````-!>M#QOE"VZ$:\7>I1<I*8\QAL6,GE4
MT<@NX1A6]BI<M!5&?F"HE.#:*;RZBK05U`!,B[U(HF`5"@(5H`*)B',#D$/Q
M@8.7^_@/*9@54(DCS654,!$TD"F654.8>0%(FD!SF,(_@`.`7CK=TP.H7MRZ
M;HZ]:?YSR`P<F0`MG]RI"L4E)-PH5,CAQ=K<6"JZ+<O:YB877L#@)*6HOHQ-
MM\A&BY[<?/\`CG7N`6,15]2<:-U,M9&!N8H&%LO+&4A*+$//E*)T7,F0@B`\
MC<A#@)6VEGIO>E1I:K$6&*P,AGG)D29JY2R3L6Z0R5(H2+8H\GL14W31IC^%
M."ANTF9&*%=/D')41#F(/KL6+&,9MH^-9M8]@S1(W:,6+=%HS:H)AV4T&S9N
M1-%!%,OL`I2@4`^0.`^K@#@(R'JXZP\G^C;D*29H'7+3LX8-LKX2%`PH,3V=
MQ75%S#_\2$6GTP$?^+@(YGPQE_X,3SOP:_\`>K^*?8[DW/RGX]>X_BOD_P#P
M[7TNW\G+@(;EB`32\R4/E%VY`/\`6//E_+P%T5T8\^UC93I<Z29,JSUHZ23P
M)1J%/(-5$SC%6[%\2CCVTQ3DA#&[APUF:VJ/8-R'L&*/R"'`.066LURYP$O5
M+?`0MJJ]@8.(J>KECBV,W!348[(*3J.EHB20<L)%BY3$2J)+)G3.'L$!X!JR
M:Z#G1YL$RZGI+I\:\#(O7)W;D6-:?Q#%1=0XJ*'"(B)9C$IE.<PB)2(%(/XN
M`4WASIQ:#:^G;+88TXUPQZ\9@3PLI`XCIA)IN*8]HAT9MU$N99-0#>WM`MVA
M'\/`+022313(BBF1))(A4TTDB%333(0`*4A"%`"D(4`Y``!R`.`]^`.`.`.`
M1;L]U%]&M,XYP_V9VCP[BAP@FHH6N3=PCGEU=]V41[#"BPIY.WOCG$.R7NF1
M@$P\N?`-4-=O].O4C:M]0+2O6Z4OL96(*C5"N%S->*;Y+!*7>U.IJ>HD_7:T
MYDBV9Y%URQ41)5WXM!BJL@?DF7F/,`53]TO2/N:ONE_>]'R_]W'X4_$KR<>X
M^)O?>]WQ&\E[[O\`P7Q0_P"Y>&[WO?#?FNWVOI<!3>SW[;E?UY?\K@)+?IX>
MO(/2XNDY@+8@L[8M,LLV)*>?O8A%Q+3N#+ZY208.[U!0Z8G7EZI/-$$B3<>W
M`7'-NFZ;%,J15%P%H%@G8C!>SN/XC*>O>6*)F''\XV1=,+/0K%'S[#LKE$Q&
M[XK-8[J)D"=D04:NTT7*1BB4Y"F`0`.R\`<!C9:9AX%FI(SDM&PL>B`BL_EG
MS6.9I``"(BHZ>*HH$``#G[3!P"`LX]6GIHZX`X)F+=W72KOFW;[R%:9(@K78
MNVF',Z1*[3W$_-J+%'V"4$.8#[/EX!F3/OK`.E5BQ-ZUQ2AG79":;*'11)1<
M>FI];<*`'T3C8LCOJTOX81'VG28K\@^0!^3@&.-B?6L;.V<9..U?U)Q-BABK
MWA(VQY:M$_E.Q(E^F5)<T3`)T:`35Y"!A(?Q!0$.7,0]H@P-LQUV>K#M@$HR
MR=N7D^"K$L"B;BD8C=-,054K=4QA.T,VH+>%D7K80-V>3IRN(E``$>`:;D7[
M^8?N967?/9:4>K'</).4=N)&0=N%#"91=R]>*+.5UCF$1$QS"(CP$^CT0'_*
M=1']>UV_Z3*O`3YN`H/9[]MROZ\O^5P&)X#K6'\^9RU[L`6O`^8\GX:L?>)J
M'F,97BQTMZN9+D)/%'@9!D5V0O9#Z*H'+_HX!S6O^H,ZSE98I1\;O_F)T@B4
MI"*6)A0[6]$I0`"]Y(V2H2<@J;D'M,=4PC^$>`U.[==?K`9":K,;'U!=A46K
M@ADUD:M8HVB`H0X"4Q1/2HB`5`!`WR`;@&_\B[$[!Y?76<98SOF3)BRXB*IK
MYDRY6D#B8.R;FG,S+M+Z11Y#[/:'`<8*BD7EV4R!R^0>0"/^T>8\!^G`'`'`
M'`3\O1`?\IU$?U[7;_I,J\!/FX"@XG5T1FI4062$!?+\A!0@@/(_(?:`_@$.
M`Q7?)?:I_7+\_`'?)?:I_7+\_`'?)?:I_7+\_`'?)?:I_7+\_`'?)?:I_7+\
M_`'?)?:I_7+\_`'?)?:I_7+\_`'?)?:I_7+\_`'?)?:I_7+\_`'?)?:I_7+\
M_`3]/0_G(9KU$0*<AA\;KL;D4Q1'LBURL4#<@'GV1,40Y_C#@)]'`,\7YOTD
M:=DBY8HC=.<-9>R-CA)DYRI7<%Z40V9G.+_-&I7[!OD-_1L;R\96YI['G!R2
M,77\T,W,57PW=G(8P=$UUQCTA]LX*Q6+7C`FE^3X^G3"5;NB4)K[C9M*TJT*
M-0>'JER@I:C1TU5K4S;F`7,:^00>MA]BJ9!Y!P&PQ^!.E?*9_L>KK#6;3]SG
M6I8PK^9+#C]/7O%XRL;CBT6&4JT)8UE!IP-!0=SD.NB*95!6('8,8H$43,8.
M&[=/.C3HJK2QV?UBUWQU'9#?)0U-L".F,;;:W.65PLHBSJ2$[3<5S\<A;)#N
MC';1ZQTW+@@"9,I@`>`^W"@=&K/67;!K[2];]8X7/E8KR5NE<*Y,U%K^)\FF
MJ*YDRIVJ(JF1<9UM_8Z[VE0`[N.!TBD/,%#$$!``Y:_RUT2V.?K7JN34[%,G
ML52F,A,V/#\+T_)66N+*M1JI4E;>DV8X969OZBX[U,6TDW65:.05("1SF'EP
M'<L"5SHX;.FOK#!^!M/+M;<6&52R3C3]VRAUW+5$<II`J5K:\5VN@0=^A%G0
M&*5N*\>1-R8Y02,?M%YAQG%.3NB9FVRYQI>,=5\.6>YZU5N1L^=:BCH.^8V3
M&K>,4.FK$3T1)X<9.U+0[!%51I%MBN'SQ%%11!-0A1-P"AM5L9](_=?$4=G7
M6;734/)V,9*:G:VE8&.MN/XA9K8*T\%C-PLI"V"AQ4W$2;!82B9%RW2.*:A%
M``2'*80Q,W2>D=";15_3(VL&L$OLA/T<F2QQS6]4Z?8G%=Q\J^<1B%PNDW$8
M]=5VFPKF0;"BB>2=MSK',0"%-VR\PWO-^!.E=KC"TRPYIUHT]H<-D+*%#PS4
M'TOK]BTJ,SDC)<P6"IE;0%&GJ]VO+2!A#O#]E%%,AE%#%(43`'']D<D8WT0=
MS%4U3P;@G!QW4#0;GG7)==QA4:[%5RM7'(7PKQD@:N5Q>ALK9/R-G>OUC+RD
MDV80D.Q=N#=\HHDB8-,^\2V$^'/EWP[@_?7X7?O`_%7W3G?(OW;O!]S[^_"#
MWC\T^(?O'^A^7>?^[_@?^]>9>`_1^+\'-_3+6RA7;I(85LM:ER6'($K><Q/-
MA+"\?*2EKL&<G60YMS8YJ[2KI5:1D[#(5U6).1=R<RAV'A@`>P!>('6V]%US
MUELFT>R#486AO[W#0F6=C7S=^W;QRQ,:U"3C6U_E8)$2$93+RJQ1T7+SL@I)
M`P3[0G.F(B$.W+6R-BUMV<TQZSMBP=MCC>VW[,UHH&^DMDC#%JJ>+DM2=BY>
M-K^$8%K;)5^K%K$P-78N"\`0B20R#\QU#]E0P%$'7O4WR[MUI#JC,TX8Z>=/
M.H7J++5A-24%C"SCM2;F7<$"TRV1>>$C9!51/FZ(FMW:1Q.4IN7(0TFB66Q[
M4^H1QS&[<4F#U3SKH?J[;K-@&@T^WK9!9;:5?-97L-;+JRR2I!TXI*CBYHY,
MG[N^`6>&D%W2RJA$VZI!#I]14/\`Q367R]LW9^Z;Q\7L]H>R)0S:].!1#GR$
M`.//E^/V\!K?4$H@U'U`O1QRC@Y`T5F+*U3V.H^Q!*XV!!Q<==*-56,BWD<@
M"R3+YA&5V3FEDF2ST3`5<J!"&[2"($#Z^E@_69]77U#+OO3CX/,.N[LH&,8Q
M0,SQ#+"F/9$>7YLA`*'XB^SY.`;6Z3V?&/2=V)DJAFJT/V>I?4QUKG=\\13,
MNY1\)6=CZ*M/J9HQ7!`OX5-S-V^"0;J,&:?)5TIY:W("BJGM!3W3DALEU?U$
MVS]AS+(SGQ6V1Z:>,L^WVK2KE15GCN4LN3:RG$8J@$C@`H0V,*HQ80XEYF[Q
M\U<+"(BJ/`;;UE(^+Z@MKV7UP:8TVBO<5JGB(C3!%TP'B"TY$J4'U`IQHAD*
M/FIBRUR5CF\?,8II4?#0ZJ)^V9J6XOCB)54DRB"H-*Y=OU?=&M:-K&]BB*QL
M14JY$X8V3I5\KLK8*1;<BX/N<7-RU4R?4X^=JMDBWT-DFOHV:'=-'K==LG)K
M-UTG35TJCP"GONL&?N%W'Q19_$?EY#Y=[J2OP"^"_C/,OW9/A=[Y>\/P7\Q_
M2?V_YIXOZ7?>$_0.`2A@+IMZ@S&8\TYRZ0_4LL.`:Y=K.U3V)P]ISDO7O/>`
M$[X1H<"NE:)+Q.1(?%=V69")P!$Z"A2<P(B"/),`4?FS1K6NS:N[#:\N]W+C
MCAQ-6&I6[=[8B=RCB^Q9RL+=L@SEX&'S+;;XQ>5[&%.DV#)JFSC$XV)C$H0I
MVK-!-!PN*@=EW[UMQEG+IYW?7[;7;)EBC#$Q7:S&YOV+FR8>QPTDJK'S<>Z0
M.\E[HR-C3'QIJ628)@]022%-0"E;]V94.0(@V=Z;N`+[I!II@;8;J?W6J:_X
M3R+BZ<P5F*RV[76J2>6+/&1[=OK7".\C6:!&LWU_#1PF&%3CDRN)\#IG."XI
ME$04'N)IMJ]G_8#1]?)NY9\(]1+!_FL]@7(-"O&'<>["9=J`-7"628-MB*PL
M91M=J%-(-')WZ#"(6;1XF<BF*15%BB&LR>B^/WO5#N^SM*ZC,_5]W)/`$52Y
M#`S4->K$\A-9$9DH0+N3P[*0:U]<007),ZZ=D7.FFM(G,F!^S^9`%98/P)K7
MB'9^V6*T9L89NWZON,&CJ=GLIWFE.\WQN!X^P+),HW'>)X((9+&F$DK6<XJ^
M31#=F]E!$SQPX<%*)02#KEHEC''VTG4,R;@_J-SELSSL(];$VZH[%77FXOL-
M6US7)1MB^26I</">>8JF*Q57I_+F\V"J4DT1*HLFMV1/P&BN-'^FW4L&]-O'
MFT>Y^/LLU?7;/<#DG1/(6;,JX%JLOE>5CFQ&5?QC"S+$(""S;$J34K'NNXBT
M%'KMRUCRF$W=D`X=;D-),3/NK58=MZ[OY,0>Y;G`B-1<ZP,Y'!<B$?J^,@5!
M@>2Q,YBSY,=5DE]$CU.R+K%*:2`J`*]C\SP"C.G]K+#ZTT?,]2HVW=DVAC+-
MFO*5JM5CMH8NG['3<[V6QOY/+T=.3V/(N)!Q+M;2[`%X:4(+J'[HK8>R0"D*
M"<>EQI/@G6+(^V-]UGWPD=GH7+^;;A8]E<=L9[!=NIE*V6<OUGMH.W;XHB63
:G$]N:)2'AY"`64`XH$;`LD!D4S"#T'`?_]D_
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
